Cargando…
Effect and limitation of neoadjuvant chemotherapy for pancreatic ductal adenocarcinoma: consideration from a new perspective
BACKGROUND: Effect of neoadjuvant chemotherapy (NAC) for pancreatic ductal adenocarcinoma (PDAC) has remained under investigation. We investigated its effect from a unique perspective and discussed its application. PATIENTS AND METHODS: We retrospecively analyzed consecutive 131 PDAC patients who un...
Autores principales: | Kurata, Yoshihiro, Shiraki, Takayuki, Ichinose, Masanori, Kubota, Keiichi, Imai, Yasuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986386/ https://www.ncbi.nlm.nih.gov/pubmed/33752677 http://dx.doi.org/10.1186/s12957-021-02192-8 |
Ejemplares similares
-
Clinical impacts of resection margin status and clinicopathologic parameters on pancreatic ductal adenocarcinoma
por: Jamiyan, Tsengelmaa, et al.
Publicado: (2020) -
Gene expression profiling of pancreatic ductal adenocarcinomas in response to neoadjuvant chemotherapy
por: Sahni, Sumit, et al.
Publicado: (2023) -
Risk stratification for predicting postoperative recurrence of gastric cancer by grade of venous invasion
por: Imai, Yasuo, et al.
Publicado: (2023) -
The Impact of Venous Invasion on the Postoperative Recurrence of pT1–3N0cM0 Gastric Cancer
por: Imai, Yasuo, et al.
Publicado: (2023) -
Pancreatic ductal adenocarcinoma: Role of chemotherapy & future perspectives
por: Tiwari, Akash, et al.
Publicado: (2018)